The global hysteroscopes market was valued at USD 259.04 million in 2023 and is expected to grow at a CAGR of 6.5% during the forecast period. The extensive rise in the use of hysteroscopes for several purposes including fertility examinations, checkup for the abnormal uterine bleeding, and transcervical sterilizations along with the rise in the number of diseases associated to females and increasing prevalence among coupled to opt for assisted reproduction technology procedures, are the key factors boosting the global market growth.
To Understand More About this Research: Request a Free Sample Report
The high advances in imaging technology, that have led to the development of 3D hysteroscopes providing more detailed and accurate images of the uterus and surrounding tissues and introduction to new products with enhanced features and capabilities are also fueling the market. For instance, in September 2021, Hologic, introduced expanded Omni Suite, that is specially designed to optimize diagnostic and operative hysteroscopy market. The new offering includes a versatile Omni 30 hysteroscope.
Moreover, the increasing healthcare expenditure especially in the emerging economies such as China, India, South Korea, and Malaysia, which has led to greater investment in medical infrastructure and equipment along with the growing prevalence of numerous types of gynecological disorders such as uterine fibroids, polyps, and endometrial hyperplasia that can be effectively treated by advance hysteroscopes, are resulting in significant traction and popularity worldwide.
Rapid emergence of coronavirus has drastically affected every industry and even healthcare services other than the treatment of COVID-19 including hysteroscope was also affected during the pandemic. The patients across the globe were being limited to very few procedures, as numbers of COVID patients was dramatically increasing worldwide.
Growth Drivers
The rapid advancements in hysteroscopy technology such as the development of miniature cameras, digital imaging, and high-definition displays, which has improved the accuracy and safety of the hysteroscopic procedures and further increases their popularity and awareness among doctors and patients along with the emergence of hysteroscopy as a preferred option for gynecological procedures, are the primary factors boosting the global market growth.
Rising government initiatives and funding from private and public institutions regarding the development of healthcare infrastructure and to promote the women health, as it includes efforts to improve access to healthcare services, increase awareness about gynecological disorders, and promote the adoption of minimally invasive surgical procedures, are also likely to have positive impact on the demand and growth of the market.
The market is primarily segmented based on product, application, end-use, and region.
By Product |
By Application |
By End-Use |
By Region |
|
|
|
|
To Understand the Scope of this Report: Speak to Analyst
The widespread use of the product in hospitals and clinics because of the availability of large range of diameters that allow for in-office and operating room procedures, are key factors propelling the segment market growth at rapid pace. The rising incidence of gynecological disorders across the globe such as uterine fibroids, endometriosis, and abnormal uterine bleeding is further influencing the growth of rigid hysteroscope segment.
The flexible hysteroscope segment is expected to grow at fastest growth rate over the coming years, which is mainly driven by its ability to provide the full visualization and also provide the better optical visualization mainly due to the higher pixel count as compared to the other product types available in the market.
The myomectomy segment held the largest market share in 2022 with a considerable growth rate, on account of its ability to perform several types of clinical conditions mainly prolonged infertility and the procedure is extremely helpful in the diagnosing of cause of various miscarriages. In addition, the popularity of minimally invasive surgical procedures has been on the rise in recent years due to their many benefits, including shorter recovery times, reduced pain, and lower risk of complications, which has led to higher adoption of the product in these procedures, as they are effective tool to perform invasive surgeries.
The endometrial ablation segment is projected to exhibit significant growth over the anticipated period, mainly due to the continuous rise in the prevalence of abnormal uterine bleeding, that affects millions of women across the world along with the growing awareness regarding the early detection and treatment of several types of gynecological problems and increased focus on women’s health and well-being.
The gynecology clinics segment is projected to grow at a healthy CAGR during the forecast period, which can be largely attributed to rising incidence of gynecological disorders such as fibroids, endometrial cancer, and polyps globally, that has led to an increase in the demand for hysteroscopy procedures. Additionally, gynecology clinics are playing a crucial role in diagnosing and treating these conditions and women are also becoming more aware about the importance of regular gynecological checkups, which in turn, has propelled the demand and growth of the segment market.
The hospitals segment led the industry market with significant revenue share in 2022, which is highly accelerated to the presence of diverse range of medical equipment and skilled doctors along with the increased number of hospitalizations for the treatment of gynecological problems. The rapid development of miniaturized hysteroscopes and integration of imaging systems in numerous hospitals, in order to provide better patient care especially in developed countries like US, Germany, France, and Canada, are further influencing the market growth.
The North America region dominated the global market for hysteroscopes in 2022 and is expected to maintain its dominance throughout the anticipated period. The growth of the regional market can be highly attributed to increasing number of favorable government reimbursement policies & regulations, quick commercialization & approval of products, and growing number of health-conscious women across the region. In addition, the rapid growth in the need and demand for invasive procedures and rising research & development activities for the improvement of gynecological systems, are some other factors fueling the growth of the market in the region.
The Asia Pacific region is projected to be the fastest growing region with a significant growth rate over the coming years, owing to surge in the number of incidences related to infertility and several other related disorders and increasing awareness regarding the women health and well-being. The exponential growth in the healthcare infrastructure development and rising investments to innovate more improved solutions for the effective treatment of these disorders in emerging economies like India, China, Malaysia, and Indonesia, will also bode well for the market growth.
Some of the major players operating in the global market include Olympus Corporation, Hologic, Medtronic, Ethicon Inc., B. Braun Melsungen, Richard Wolf, XION, Stryker Corporation, Silex Medical, Smith + Nephew, PENTAX Medical, Life Care Medical, KARL STORZ., Huge LLC, FUJIFILM Corporation, Conmed Corporation, Laborie Inc., Boston Scientific, SonoScape Medical, and Alltion Ltd.
Report Attributes |
Details |
Market size value in 2024 |
USD 275.25 million |
Revenue forecast in 2032 |
USD 456.57 million |
CAGR |
6.5% from 2024– 2032 |
Base year |
2023 |
Historical data |
2019– 2022 |
Forecast period |
2024– 2032 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2024 to 2032 |
Segments covered |
By Product, By Application, By End-Use, By Region |
Regional scope |
North America, Europe, Asia Pacific, Latin America; Middle East & Africa |
Key companies |
Olympus Corporation, Hologic Inc., Medtronic, Ethicon Inc., B. Braun Melsungen AG, Richard Wolf GmbH, XION, Stryker Corporation, Silex Medical LLC, Smith + Nephew, PENTAX Medical, Life Care Medical Devices, KARL STORZ SE & Co., Huge LLC, FUJIFILM Corporation, Conmed Corporation, Laborie Inc., Boston Scientific Corporation, SonoScape Medical Corporation, and Alltion Ltd. |
The Hysteroscopes Market report covering key are product, application, end-use, and region.
Hysteroscopes Market Size Worth $ 456.57 Million By 2032.
The global hysteroscopes market expected to grow at a CAGR of 6.5% during the forecast period.
North America is leading the global market.
key driving factors in Hysteroscopes Market Increase in Incidence of Uterine Diseases and Abnormalities.